Drug Research
FDA And NIH Working Together To Discover More About ALS
The Critical Path for Rare Neurodegenerative Diseases (CP-RND), a new public-private partnership created to advance the development of treatments for amyotrophic lateral sclerosis (ALS) and similar rare neurodegenerative conditions, has been initiated by the US Food and Drug Administration...
News
Naturopathic Solutions to Keep Your Immune System Healthy
You know you should get a flu shot every year to help keep your immune system strong, but what else can you do to help protect yourself? Naturopathic solutions can be a great way to boost your immune system...
News
COVID Increases Long-Term Brain Injury Concern- US Study
According to a study published on September 22nd by U.S. researchers, those who had COVID-19 were more likely to experience a variety of brain damage a year later than those who had never had the coronavirus. This result may have...
News
New Global Survey Reveals Shift in Clinical Trial Priorities; Payment Efficiencies Emerge as Leading Concern for Sponsors, CROs and Sites
Greenphire, the global leader in financial lifecycle management for clinical trials, announced results from its 2022 annual market trends survey which examined top challenges and opportunities for sponsors, CROs, and sites across the globe. While survey respondents represented a...
Drug Research
Advanced Cancers Are Tackled By Genetically Altered Herpes
A quarter of patients with a variety of advanced tumours have shown signals of benefit from RP2, a modified form of the herpes simplex virus, according to research. The trial's participants had malignancies of the head and neck, oesophagus,...
Drug Research
EC Authorizes Opdualag From BMS As A Melanoma Treatment
The fixed-dose combination Opdualag (nivolumab and relatlimab) from Bristol Myers Squibb (BMS) has received clearance from the European Commission for use as the first-line therapy for advanced unresectable or metastatic melanoma.
Patients aged 12 years and older who have cancer...
News
GAVI Funds To Enable Quick Finances For The Next Pandemic
According to Chief Executive Seth Berkley of the global vaccination alliance GAVI, the organisation has set up financial structures that would enable it to quickly access pledged donor cash in the event that it needs to purchase vaccines for...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read